The Rever Rundown with Mimi Deal
Activehealthfitnessalternative

The Rever Rundown with Mimi Deal

Insights from recent episode analysis

Audience Interest

Estimated Reach: 5K to 30K
Listeners across platforms

Podcast Focus

Categories: health · fitness
+1 more

Publishing Consistency

Frequency: ~3-4 / Week
11 episodes since 2026

Platform Reach

Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.

Medium Confidence

Total monthly reach

5K to 30K

Estimated from 1 chart position in 1 market.

By chart position

  • 🇺🇸
    US · Alternative Health
    #116
    5K to 30K
  • Per-Episode Audience

    Est. listeners per new episode within ~30 days

    2.5K to 15K
    🎙 ~2x weekly·11 episodes·Last published 4d ago
  • Monthly Reach

    Unique listeners across all episodes (30 days)

    5K to 30K
    🇺🇸100%
  • Active Followers

    Loyal subscribers who consistently listen

    2K to 12K

Market Insights

This ShowCategory Avg
No category insights available.
📡

Platform Distribution

Reach across major podcast platforms, updated hourly

Total Followers

Total Plays

Total Reviews

YouTube

YouTube

Subscribers

Views

Videos

Castbox

Castbox

Followers

Plays

Reviews

Podcast App

Podcast App

Followers

Plays

Reviews

Podcast Republic

Podcast Republic

Followers

Plays

Reviews

TuneIn

TuneIn

Followers

Plays

Reviews

* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.

On the show

Recent episodes

Episode 18: GHK-Cu: The Copper Peptide Shaping Modern Longevity Protocols

Jun 1, 2026

Unknown duration

Episode 17: Peptides, Hormones & IV Therapy: A Functional Medicine Conversation with Jason Pencek

May 25, 2026

Unknown duration

Episode 16: Peptides 101: What They Are, How They Work, and How to Use Them Safely

May 18, 2026

Unknown duration

Episode 15: Compounding Pharmacies and Personalized Hormone Therapy with Dr. Luis Delgado

May 11, 2026

Unknown duration

Episode 14: Testosterone in Women: Benefits, Risks, and Why It's Under-prescribed

May 4, 2026

Unknown duration

🔗

Social Links & Contact

Official channels & resources

🌐

Official Website

Login

📡

RSS Feed

Login

Chart Positions

1 placement across 1 market.